* Globus Medical Inc GMED.N GMED.K is expected to show a
rise
in quarterly revenue when it reports results on August 6 for
the period ending June 30 2024
* The Audubon Pennsylvania-based company is expected to
report a
111.0% increase in revenue to $615.345 million from $291.62
million a year ago, according to the mean estimate from 14
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Globus Medical Inc is
for
earnings of 68 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Globus
Medical
Inc is $72.00, above its last closing price of $69.10.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 0.56 0.57 0.72 Beat 26.9
Jan. 1 2024 0.59 0.61 0.60 Missed -1.6
Sep. 30 2023 0.56 0.57 0.57 Met -0.3
Jan. 1 0001 0.60 0.59 0.63 Beat 6.2
Jan. 0.51 0.51 0.53 Beat 4.2
1 0001
Jan. 1 0001 0.57 0.56 0.59 Beat 5.3
Jan. 1 0001 0.52 0.52 0.50 Missed -3.9
Jun. 30 2022 0.54 0.53 0.56 Beat 4.9
This summary was machine generated August 2 at 22:53 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)